Amy Chevalier Efantis
Government post most recently disclosed: Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett
The register gives a lobbyist a separate record at each firm. This person is very likely also listed as Amy Efantis (Pharmaceutical Research And Manufacturers Of America), Amy Efantis (Boehringer Ingelheim Usa Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc), Amy Efantis (Biogen), Amy Efantis (Plasma Protein Therapeutics Association), Amy Efantis (Gsk (fka Glaxosmithkline Inc.)), with the same name and the same covered position. The register itself does not confirm these are one person.
Lobby filings counts every filing that names this lobbyist, amendments included. Contributions come from the twice-yearly LD-203 reports, counting the current version of each report once.
Lobbying filings
| Filing | Firm | Client | Amount |
|---|---|---|---|
| 3rd Quarter - Report 3rd Quarter 2026 |
LMH STRATEGIC SOLUTIONS | MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | $120,000 reported |
| 2nd Quarter - Report 2nd Quarter 2026 |
LMH STRATEGIC SOLUTIONS | MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | $230,000 reported |
| 1st Quarter - Report 1st Quarter 2026 |
LMH STRATEGIC SOLUTIONS | MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | $230,000 reported |
| Registration 1st Quarter 2026 |
LMH STRATEGIC SOLUTIONS | MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | — reported |
Political contributions
Contribution reports (LD-203)
Every report the register holds. A report replaced by a later version is listed but not counted.
From reports filed under the Lobbying Disclosure Act: LD-2 reports name the lobbyists who worked on each issue, and LD-203 reports list their political contributions twice a year.